MAMSTR: A Protein Implicated in Immune Response and Cellular Processes

Target Name: MAMSTR

NCBI ID: G284358

MAMSTR

Other Name(s): MASTR_HUMAN | MEF2-activating SAP transcriptional regulatory protein | MASTR | likely ortholog of MEF2-activating SAP transcriptional regulator | MEF2-activating SAP transcriptional regulator | MEF2-activating motif and SAP domain-containing transcriptional regulator (isoform 1) | MEF2 activating motif and SAP domain containing transcriptional regulator, transcript variant 1 | MEF2-activating motif and SAP domain-containing transcriptional regulator | MEF2 activating motif and SAP domain containing transcriptional regulator | MAMSTR variant 1

MAMSTR: A Protein Implicated in Immune Response and Cellular Processes

MAMSTR (MASTR_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, kidneys, and liver. It is a key regulator of the immune system and has been implicated in a number of diseases, including cancer , neurodegenerative diseases, and autoimmune disorders.

One of the key functions of MAMSTR is its role in the immune response. MAMSTR has been shown to play a key role in the regulation of T cell development and function, which are critical for the immune system's ability to recognize and respond to foreign threats. MAMSTR has also been shown to regulate the production of antibodies, which are proteins that help to neutralize toxins and pathogens in the body.

In addition to its role in the immune system, MAMSTR has also been implicated in a number of other processes that are important for human health. For example, MAMSTR has been shown to play a key role in the regulation of cell death, which is important for the development and maintenance of tissues throughout the body. MAMSTR has also been shown to be involved in the regulation of cell signaling, which is important for the regulation of a wide range of cellular processes that are essential for human health.

Despite its importance for a number of important biological processes, MAMSTR is not yet a well-studied protein. There are only a few studies that have investigated the functions of MAMSTR, and more research is needed to fully understand its role in the immune system and other processes.

One potential drug target for MAMSTR is the use of small molecules that can modulate its activity. For example, researchers have shown that inhibitors of the protein kinase A (PKA) can reduce the activity of MAMSTR, which suggests that MAMSTR may be a target for drugs that inhibit PKA signaling. Similarly, researchers have shown that MAMSTR is involved in the regulation of cell signaling, which suggests that drugs that can modulate signaling pathways may be effective in treating diseases that are caused by the regulation of signaling pathways.

Another potential drug target for MAMSTR is the use of antibodies that can target MAMSTR and modulate its activity. For example, researchers have shown that antibodies against MAMSTR can neutralize toxins and pathogens in the body, which suggests that MAMSTR may be an attractive target for vaccines or other treatments that are designed to protect against these types of toxins.

In conclusion, MAMSTR is a protein that is expressed in various tissues of the human body and is involved in a number of important biological processes. While more research is needed to fully understand its role in the immune system and other processes, the potential for drugs that can modulate its activity makes it an attractive target for future research and treatment.

Protein Name: MEF2 Activating Motif And SAP Domain Containing Transcriptional Regulator

Functions: Transcriptional coactivator. Stimulates the transcriptional activity of MEF2C. Stimulates MYOD1 activity in part via MEF2, resulting in an enhancement of skeletal muscle differentiation (By similarity)

The "MAMSTR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAMSTR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets